The Oncogenomics section of the Genetics Branch is a multidisciplinary and interdisciplinary translational research programmatic effort with the goal of utilizing genomics, epigenetics, proteomics, single cell technologies, CRISPR/Cas9 strategies and molecular/cell biology methods to identify targets and develop novel therapies for cancer. We work with other investigators within the intramural program as well as academic, industrial, and pharmaceutical partners to rapidly translate our findings to the clinic.
The program takes advantage of the uniqueness of the National Cancer Institute, (NCI), Center for Cancer Research (CCR) intramural program in that it spans high-risk basic discovery research in immunology, genomics and tumor biology, through preclinical translational research, to paradigm-shifting clinical trials.
The positions are available immediately.
Additional information can be found on Dr. Khan’s profile page: https://ccr.cancer.gov/Genetics-Branch/javed-khan
We are looking for newly graduated postdoctoral candidates with first author publications and experience in genomics molecular and cell biology. Candidates are required to have a PhD or MD degree, or equivalent, in molecular/cell biology or biological sciences. Experience in molecular/cell biology, CRISPR/Cas9 and/or epigenetics preferred but not essential.
Stipends are commensurate with education and experience.
DHHS, NIH, and NCI are Equal Opportunity Employers
Additional Application Instructions
Applicants should submit a cover letter describing their research experience and interests, CV including bibliography, and contact information for three references to: Dr. Javed Khan, M.D., via e-mail: email@example.com. No calls, please. If we are interested, you will be contacted by Dr. Khan.